Orchard Capital Management’s Akebia Therapeutics AKBA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $146K | Hold |
|
|||||
|
2025
Q2 | $195K | Hold |
|
|||||
|
2025
Q1 | $103K | Sell |
|
|||||
|
2024
Q4 | $115K | Sell |
|
|||||
|
2024
Q3 | $112K | Sell |
|
|||||
|
2024
Q2 | $88.6K | Sell |
|
|||||
|
2024
Q1 | $198K | Buy |
|
|||||
|
2023
Q4 | $108K | Buy |
|
|||||
|
2023
Q3 | $76.2K | Hold |
|
|||||
|
2023
Q2 | $61.1K | Hold |
|
|||||
|
2023
Q1 | $37.4K | Hold |
|
|||||
|
2022
Q4 | $38.6K | Sell |
|
|||||
|
2022
Q3 | $80K | Hold |
|
|||||
|
2022
Q2 | $89K | Sell |
|
|||||
|
2022
Q1 | $1.26M | Buy |
|
|||||
|
2021
Q4 | $3.6M | Hold |
|
|||||
|
2021
Q3 | $4.59M | Hold |
|
|||||
|
2021
Q2 | $6.04M | Buy |
|
|||||
|
2021
Q1 | $5.21M | Buy |
|
|||||
|
2020
Q4 | $2.4M | Buy |
|